BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31955622)

  • 1. Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease.
    Shirey KA; Lai W; Brown LJ; Blanco JCG; Beadenkopf R; Wang Y; Vogel SN; Snyder GA
    Innate Immun; 2020 Jan; 26(1):26-34. PubMed ID: 31955622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4.
    Wong EB; Mallet JF; Duarte J; Matar C; Ritz BW
    Nutr Res; 2014 Apr; 34(4):318-25. PubMed ID: 24774068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury.
    Zhang RH; Li CH; Wang CL; Xu MJ; Xu T; Wei D; Liu BJ; Wang GH; Tian SF
    Int Immunopharmacol; 2014 Sep; 22(1):1-8. PubMed ID: 24968347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
    Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
    Front Immunol; 2018; 9():295. PubMed ID: 29515589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.
    Wu CC; Crain B; Yao S; Sabet M; Lao FS; Tawatao RI; Chan M; Smee DF; Julander JG; Cottam HB; Guiney DG; Corr M; Carson DA; Hayashi T
    J Innate Immun; 2014; 6(3):315-24. PubMed ID: 24192551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.
    Zhou HX; Li RF; Wang YF; Shen LH; Cai LH; Weng YC; Zhang HR; Chen XX; Wu X; Chen RF; Jiang HM; Wang C; Yang M; Lu J; Luo XD; Jiang Z; Yang ZF
    Phytomedicine; 2020 Oct; 77():153272. PubMed ID: 32702592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection.
    Shirey KA; Sunday ME; Lai W; Patel MC; Blanco JCG; Cuttitta F; Vogel SN
    Mucosal Immunol; 2019 Jan; 12(1):223-231. PubMed ID: 30327535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.
    Mifsud EJ; Tan AC; Reading PC; Jackson DC
    Immunol Cell Biol; 2016 Feb; 94(2):169-76. PubMed ID: 26272554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel strategies for targeting innate immune responses to influenza.
    Shirey KA; Lai W; Patel MC; Pletneva LM; Pang C; Kurt-Jones E; Lipsky M; Roger T; Calandra T; Tracey KJ; Al-Abed Y; Bowie AG; Fasano A; Dinarello CA; Gusovsky F; Blanco JC; Vogel SN
    Mucosal Immunol; 2016 Sep; 9(5):1173-82. PubMed ID: 26813341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.
    Vono M; Eberhardt CS; Mohr E; Auderset F; Christensen D; Schmolke M; Coler R; Meinke A; Andersen P; Lambert PH; Mastelic-Gavillet B; Siegrist CA
    Front Immunol; 2018; 9():381. PubMed ID: 29541075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway.
    Tian J; Jiao X; Wang X; Geng J; Wang R; Liu N; Gao X; Griffin N; Shan F
    Int Immunopharmacol; 2018 Feb; 55():38-48. PubMed ID: 29220721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.
    Shi X; Zhou W; Huang H; Zhu H; Zhou P; Zhu H; Ju D
    Crit Care; 2013 Dec; 17(6):R301. PubMed ID: 24373231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia.
    Aoyagi T; Newstead MW; Zeng X; Kunkel SL; Kaku M; Standiford TJ
    Mucosal Immunol; 2017 Jul; 10(4):1043-1055. PubMed ID: 27966554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infection.
    Wang X; Lin X; Zheng Z; Lu B; Wang J; Tan AH; Zhao M; Loh JT; Ng SW; Chen Q; Xiao F; Huang E; Ko KH; Huang Z; Li J; Kok KH; Lu G; Liu X; Lam KP; Liu W; Zhang Y; Yuen KY; Mak TW; Lu L
    Nat Commun; 2021 Mar; 12(1):1914. PubMed ID: 33772013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TLR4 antagonist Eritoran protects mice from lethal influenza infection.
    Shirey KA; Lai W; Scott AJ; Lipsky M; Mistry P; Pletneva LM; Karp CL; McAlees J; Gioannini TL; Weiss J; Chen WH; Ernst RK; Rossignol DP; Gusovsky F; Blanco JC; Vogel SN
    Nature; 2013 May; 497(7450):498-502. PubMed ID: 23636320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-36γ Protects against Severe Influenza Infection by Promoting Lung Alveolar Macrophage Survival and Limiting Viral Replication.
    Wein AN; Dunbar PR; McMaster SR; Li ZT; Denning TL; Kohlmeier JE
    J Immunol; 2018 Jul; 201(2):573-582. PubMed ID: 29848754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity.
    Lauder SN; Taylor PR; Clark SR; Evans RL; Hindley JP; Smart K; Leach H; Kidd EJ; Broadley KJ; Jones SA; Wise MP; Godkin AJ; O'Donnell V; Gallimore AM
    Thorax; 2011 May; 66(5):368-74. PubMed ID: 21310755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.